Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREGNANT Short Cervix Trial of vaginal progesterone for prevention of preterm birth
2008-007498-19Phase 3Completed
- Sponsor
- Columbia Laboratories
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of progesterone in preterm birth, sponsored by Columbia Laboratories. Primary endpoint: Preterm delivery at or before 32 6/7 weeks. Started Jul 2009; status: completed.
02
Drugs
progesterone
03
Conditions
preterm birth
Beyond the preview
Go deeper on 2008-007498-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007498-19.